Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for inhibition of remifentanil-induced hyperalgesia after laparoscopic cholecystectomy
ChiCTR-TRC-13003731Phase 4Completed
- Sponsor
- Zhenjiang First People's Hospital
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Postoperative hyperalgesia (2 arms), sponsored by Zhenjiang First People's Hospital. Primary endpoint: VAS pain score. Started Nov 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Postoperative hyperalgesia
Beyond the preview
Go deeper on ChiCTR-TRC-13003731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003731.